TrialThe British journal of dermatology2019

Sustained long-term efficacy and safety of adalimumab in paediatric patients with severe chronic plaque psoriasis from a randomized, double-blind, phase III study.

D Thaçi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.